Ryberg Joins Healthcare Mission to Liverpool and Manchester

Ryberg, a leading healthcare technology company specializing in advanced pathogen management solutions, is proud to announce its membership in Taskforce Healthcare and participation in the Life Sciences & Health Trade Mission to Liverpool and Manchester.

This mission involves engaging with a diverse array of healthcare stakeholders, including public, private, and academic hospitals, knowledge and research institutes, and vital health networks in the UK.

The United Kingdom has seen a significant surge in healthcare spending in response to the challenges posed by the COVID-19 pandemic in 2021. Cheshire and Merseyside, with a combined population of 2.5 million individuals requiring healthcare services, offer promising collaboration opportunities. The proximity to the Netherlands, shared culture, and patient-oriented approach create an ideal environment for seamless follow-up and cooperation. Notably, the presence of innovative healthcare providers and the Manchester and Liverpool University Hospitals NHS Foundation Trusts make these regions attractive destinations for Ryberg's expansion efforts.

Digitalization and new technologies, particularly those driven by artificial intelligence and robotics, are pivotal in ensuring accessibility, affordability, and quality of care. The UK's substantial investment in Life Sciences & Health (LSH) innovations provides a unique opportunity for Ryberg to leverage its expertise in pathogen management solutions. By investing in these transformative technologies, Ryberg aims to position the Netherlands advantageously, fostering collaborative initiatives that drive innovation and enhance healthcare outcomes.

Ryberg's participation in Taskforce Healthcare and its engagement with the healthcare landscape in Liverpool and Manchester mark a significant step towards building international partnerships and advancing innovative solutions in pathogen management.